Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerus (CERS) Cash & Equivalents (2016 - 2025)

Cerus (CERS) has disclosed Cash & Equivalents for 16 consecutive years, with $20.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 1.5% to $20.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.0 million through Dec 2025, down 1.5% year-over-year, with the annual reading at $20.0 million for FY2025, 1.5% down from the prior year.
  • Cash & Equivalents hit $20.0 million in Q4 2025 for Cerus, up from $15.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $78.5 million in Q3 2021 to a low of $11.6 million in Q4 2023.
  • Historically, Cash & Equivalents has averaged $30.1 million across 5 years, with a median of $21.1 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: surged 171.02% in 2021 and later crashed 67.27% in 2023.
  • Year by year, Cash & Equivalents stood at $48.8 million in 2021, then dropped by 27.02% to $35.6 million in 2022, then plummeted by 67.27% to $11.6 million in 2023, then surged by 74.0% to $20.3 million in 2024, then decreased by 1.5% to $20.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for CERS at $20.0 million in Q4 2025, $15.7 million in Q3 2025, and $16.0 million in Q2 2025.